|
1. Pihlstrom BL, Michalowicz BS, Johnson NW.
Periodontal diseases. Lancet 2005; 366(9499):
1809-20. 2. Kinane DF. Causation and pathogenesis of
periodontal disease. Periodontol 2000 2001; 25
(1):8-20. 3. Duarte PM, da Rocha M, Sampaio E, Mestnik
MJ, Feres M, Figueiredo LC, et al. Serum levels of
cytokines in subjects with generalized chronic
and aggressive periodontitis before and after
non-surgical periodontal therapy: a pilot study.
J Periodontol 2010;81(7):1056-63. 4. Rosalem W, Rescala B, Teles R, Fischer R,
Gustafsson A, Figueredo C. Effect of non‐surgical
treatment on chronic and aggressive
periodontitis: clinical, immunologic, and
microbiologic findings. J Periodontol 2011; 82
(7):979-89 . 5. Teng MW, Bowman EP, McElwee JJ, Smyth MJ,
Casanova J-L, Cooper AM, et al. IL-12 and IL-23
cytokines: from discovery to targeted therapies
for immune-mediated inflammatory diseases.
Nat Med 2015;21(7):717. 6. Iwakura Y, Ishigame H. The IL-23/IL-17 axis
in inflammation. J Clin Invest. 2006; 116(5):
1218-22. 7. Jin W, Dong C. IL-17 cytokines in immunity
and inflammation. Emerg Microbes Infect 2013;
2(1):e60. 8. Kuwabara T, Ishikawa F, Kondo M, Kakiuchi
T. The role of IL-17 and related cytokines in
inflammatory autoimmune diseases. Mediators
Inflamm. 2017;2017. 9. Ohyama H, Kato-Kogoe N, Kuhara A,
Nishimura F, Nakasho K, Yamanegi K, et al. The
involvement of IL-23 and the Th17 pathway in
periodontitis. J Dent Res 2009;88(7):633-8. 10. Kramer JM, Gaffen SL. Interleukin-17: a new
paradigm in inflammation, autoimmunity, and
therapy. J Periodontol 2007;78(6):1083-93. 11. Lubberts E, Koenders MI, OppersWalgreen
B, van den Bersselaar L, Coenende Roo CJ,
Joosten LA, et al. Treatment with a neutralizing
anti‐murine interleukin‐17 antibody after the
onset of collagen‐induced arthritis reduces joint
inflammation, cartilage destruction, and bone
erosion. Arthritis Rheum 2004;50(2):650-9. 12. Lubberts E. The IL-23–IL-17 axis in
inflammatory arthritis. Nat Rev Rheumatol
2015;11(7):415. 13. Beklen A, Ainola M, Hukkanen M, Gürgan C,
Sorsa T, Konttinen Y. MMPs, IL-1, and TNF are
regulated by IL-17 in periodontitis. J Dent Res
2007;86(4):347-51. 14. Sørensen LK, HavemosePoulsen A, Bendtzen
K, Holmstrup P. Aggressive periodontitis and
chronic arthritis: blood mononuclear cell gene
expression and plasma protein levels of
cytokines and cytokine inhibitors. J Periodontol
2009;80(2):282-9. 15. Zhao L, Zhou Y, Xu Y, Sun Y, Li L, Chen W.
Effect of non‐surgical periodontal therapy on
the levels of Th17/Th1/Th2 cytokines and their
transcription factors in Chinese chronic
periodontitis patients. J Clin Periodontol 2011;
38(6):509-16. 16. Isailovic N, Daigo K, Mantovani A, Selmi C.
Interleukin-17 and innate immunity in
infections and chronic inflammation. J
Autoimmun. 2015 Jun 1;60:1-1. 17. Wu L, Chen X, Zhao J, Martin B, Zepp JA, Ko
JS, Gu C, Cai G, Ouyang W, Sen G, Stark GR. A
novel IL-17 signaling pathway controlling
keratinocyte proliferation and tumorigenesis
via the TRAF4–ERK5 axis. J Exp Med. 2015 Sep
21;212(10):1571-87. 18. Bettelli E, Korn T, Kuchroo VK. Th17: the
third member of the effector T cell trilogy. Curr
Opin Immunol 2007;19(6):652-7. 19. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker
PJ, Smith JB, Evans RT, Gaffen SL. An essential
role for IL-17 in preventing pathogen-initiated
bone destruction: recruitment of neutrophils to
inflamed bone requires IL-17 receptor–
dependent signals. Blood. 2007 May 1;109(9):
3794-802. 20. Nejadi R, Sattari M, Taleghani F. Assessment
of non-surgical Periodontal Therapy on IL-22
and S100A12 Concentration in Gingival
Crevicular Fluid. J Clin Diagn Res 2018;12(12):
19-23. 21. Sadeghi R, Sattari M, Dehghan F, Akbari S.
Interleukin-17 and interleukin-23 levels in
gingival crevicular fluid of patients with chronic
and aggressive periodontitis. Cent Eur J
Immunol 2018;43(1):76-80. 22. Pradeep AR, Hadge P, Chowdhry S, Patel S,
Happy D. Exploring the role of Th1 cytokines:
interleukin-17 and interleukin-18 in
periodontal health and disease. J Oral Sci 2009;
51(2):261-6.
|
